Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Experimental Hematology|January 25, 2012
Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimenNishitha Reddy, John P Greer, Stacey Goodman, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 31, 2021
Ozone Responsive Gene Expression as a Model for Describing Repeat Exposure Response Trajectories and Interindividual Toxicodynamic Variability In VitroEmma C Bowers, Elizabeth M Martin, Annie M Jarabek, et al.
Blood|July 24, 2019
Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non-germinal center B-cell-like DLBCLAndre Goy, Radhakrishnan Ramchandren, Nilanjan Ghosh, et al.
Leukemia & Lymphoma|April 12, 2003
Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classificationEdward R Arrowsmith, William R Macon, Marsha C Kinney, et al.
Leukemia & Lymphoma|September 6, 2007
High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomesBrian G Engelhardt, Derek W Holland, Stephen J Brandt, et al.
Leukemia & Lymphoma|June 12, 2019
Clinicopathologic correlates of MYD88 L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphomaTarsheen K Sethi, Alexandra E Kovach, Natalie S Grover, et al.
The Lancet. Haematology|August 28, 2020
Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trialCatherine S Diefenbach, Fangxin Hong, Richard F Ambinder, et al.
Frontiers in Immunology|December 3, 2025
Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphomaLilit Karapetyan, Joel Kuriakose, Matthew C Perez, et al.
Pageof 2